🔴 GT Biopharma is trading 6.25% down today amid a 2.06% drop in biotech ETF XBI

GT Biopharma is trading at $6.90, down 6.25%, amid pressure on small-cap biotech stocks, with biotech ETF XBI down 2.06%.

• No new company-specific announcement directly explaining the October 16 decline was identified.
• A registration reported October 9 covers up to 13.5 million shares offered by selling stockholders, not the company; it was not a new October 16 announcement.